Cargando…
Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications
AIMS/INTRODUCTION: Adiponectin is generally regarded as a beneficial molecule, protecting against insulin resistance and atherosclerosis, and its serum levels are low in individuals with obesity as well as in those with type 2 diabetes (T2DM). However, several clinical studies have shown association...
Autores principales: | Satoh, Ken, Nagasawa, Kan, Takebe, Noriko, Kinno, Hirofumi, Shozushima, Masaharu, Onodera, Ken, Oda, Tomoyasu, Hasegawa, Yutaka, Satoh, Jo, Ishigaki, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882416/ https://www.ncbi.nlm.nih.gov/pubmed/36760589 http://dx.doi.org/10.2147/DMSO.S387744 |
Ejemplares similares
-
Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis
por: Takebe, Noriko, et al.
Publicado: (2023) -
Serum C‐X‐C motif chemokine ligand 14 levels are associated with serum C‐peptide and fatty liver index in type 2 diabetes mellitus patients
por: Matsushita, Yuriko, et al.
Publicado: (2020) -
The Effects of Imeglimin on the Daily Glycemic Profile Evaluated by Intermittently Scanned Continuous Glucose Monitoring: Retrospective, Single-Center, Observational Study
por: Oda, Tomoyasu, et al.
Publicado: (2022) -
Evaluation of High Intracranial Plaque Prevalence in Type 2 Diabetes Using Vessel Wall Imaging on 7 T Magnetic Resonance Imaging
por: Shozushima, Masaharu, et al.
Publicado: (2023) -
The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”
por: Ito, Ryuichi, et al.
Publicado: (2017)